Approaches to Cardiovascular Diseases

  • Kyung Bong Koh


Potential psychosocial risk factors of coronary heart disease (CHD) include type A personality, hostility and anger, alexithymia, type D personality, stress, depression, anxiety, denial, and social support. These patients often show psychopathology such as anxiety, depression, and delirium. Psychotherapeutic interventions and psychopharmacotherapy for these psychopathologies were reviewed. Psychotherapeutic interventions with heart disease patient are aimed at reducing anxiety and depression, enhancing compliance, and modifying risk factors. To treat them effectively, the clinician should look beyond the symptoms to their function and meaning. In psychopharmacotherapy, interactions between cardiac drugs and psychiatric drugs need to be examined in addition to cardiac side effects of psychiatric drugs and psychiatric side effects of cardiovascular drugs. For the mentally ill cardiac patients, it is desirable to combine psychiatric treatment with a cardiac rehabilitation. Physicians need to keep in mind that countertransference might influence the progress of a cardiac disease.


Psychosocial risk factors Coronary heart disease (CHD) Anxiety Depression Delirium Psychotherapeutic interventions Psychopharmacotherapy Cardiac rehabilitation 


  1. 1.
    Sadock BJ, Sadock VA. Synopsis of psychiatry – behavioral sciences/clinical psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 829–31.Google Scholar
  2. 2.
    Hermann-Lingen C, Meinertz T. Psychosomatic aspects of coronary heart disease. Internist. 2010;51:826–35.Google Scholar
  3. 3.
    Lloyd GG, Cawly RH. Psychiatric morbidity in men one week after first acute myocardial infarction. Br Med J. 1978;2:1453–4.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Cassem NH, Hackett TP. Psychological aspects of myocardial infarction. Med Clin N Am. 1977;61:711–21.PubMedGoogle Scholar
  5. 5.
    Friedman M, Rosenman RH. Association of specific overt behavior pattern with blood and cardiovascular findings. J Am Med Assoc. 1959;169:1286–96.PubMedGoogle Scholar
  6. 6.
    Rosenman RH, Friedman M. Association of specific behavior pattern in women with blood and cardiovascular findings. Circulation. 1961;24:1173–84.PubMedGoogle Scholar
  7. 7.
    Kornitzer M, Kittel F, De Backer G. The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease. Psychosom Med. 1981;43:133–45.PubMedGoogle Scholar
  8. 8.
    De Backer G, Kornitzer M, Kittel F. Behavior, stress and psychological traits as risk factors. Prev Med. 1983;12:32–6.PubMedGoogle Scholar
  9. 9.
    Eaker AD, Abbott RD, Kannel WB. Frequency of uncomplicated angina pectoris in type A compared with type B persons (the Framingham Study). Am J Cardiol. 1989;63:1042–5.PubMedGoogle Scholar
  10. 10.
    Blumenthal JA, Willams RB, Kong Y, et al. Type A behavior and angiographically documented coronary disease. Circulation. 1978;58:634–9.PubMedGoogle Scholar
  11. 11.
    Frank KA, Heller SS, Kornfeld DS, et al. Type A behavior pattern and coronary atherosclerosis. J Am Med Assoc. 1978;240:761–3.Google Scholar
  12. 12.
    Williams RB Jr, Haney TL, Lee KL. Type A behavior, hostility and coronary atherosclerosis. Psychosom Med. 1980;42:539–49.PubMedGoogle Scholar
  13. 13.
    Williams RB Jr, Barefoot JC, Haney TL, et al. Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. Psychosom Med. 1988;50:139–52.PubMedGoogle Scholar
  14. 14.
    Dembroski TM, MacDougall JM, Williams RB, et al. J. Components of type A hostility and anger-in: relationship to angiographic findings. Psychosom Med. 1985;47:219–33.PubMedGoogle Scholar
  15. 15.
    MacDougall JM, Dembroski TM, Dimsdale JE, et al. Components of type A hostility and anger-in: further relationship to angiographic findings. Health Psychol. 1985;4:137–52.PubMedGoogle Scholar
  16. 16.
    Dimsdale JE, Hackett TP, Hutter AM, et al. Type A personality and extent of coronary atherosclerosis. Am J Cardiol. 1978;42:583–6.PubMedGoogle Scholar
  17. 17.
    Dimsdale JE, Hackett TP, Hutter AM, et al. Type A behavior and angiographic findings. J Psychosom Res. 1979;23:273–6.PubMedGoogle Scholar
  18. 18.
    Kornitzer M, Magotteau V, Degre V, et al. Angiographic findings and the type A behavior pattern assessed by means of the Bortner Scale. J Behav Med. 1982;5:313–9.PubMedGoogle Scholar
  19. 19.
    Scherwitz L, McKelvain R, Laman C, et al. Type A behavior, self-involvement and coronary atherosclerosis. Psychosom Med. 1983;45:47–57.PubMedGoogle Scholar
  20. 20.
    Cottington EM, Brock BM, House JS, et al. Psychosocial factors and blood pressure in the Michigan statewide blood pressure survey. Am J Epidemiol. 1985;121:515–29.PubMedGoogle Scholar
  21. 21.
    Diamond EL. The role of anger and hostility in essential hypertension and coronary heart disease. Psychol Bull. 1982;92:410–33.PubMedGoogle Scholar
  22. 22.
    Dimsdale JE, Pierce C, Schoenfield D, et al. Suppressed anger and blood pressure: the effect of race, sex, social class, obesity and age. Psychosom Med. 1986;48:430–5.PubMedGoogle Scholar
  23. 23.
    Hackett TP, Rosenbaum TF, Caddem NH. Cardiovascular disorders. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry, vol. 2. 5th ed. Baltimore: Williams & Wilkins; 1989.Google Scholar
  24. 24.
    Spielberger CD, Johnson EH, Russell SF, et al. The experience and expression of anger: construction and validation of an anger expression scale. In: Chesney MA, Rosenman RH, editors. Anger and hostility in cardiovascular and behavioral disorders. Washington, DC: Hemisphere; 1985.Google Scholar
  25. 25.
    Koh KB, Kim SJ. Comparison of anger between patients with essential hypertension and normal controls. Kor J Psychosom Med. 1995;3:19–27.Google Scholar
  26. 26.
    Jenkins CD, Rosenman RH, Friedman M. Components of the coronary-prone behavior pattern: their relation to silent myocardial infarction and blood lipids. J Chron Dis. 1966;19:599–606.PubMedGoogle Scholar
  27. 27.
    Hecker MHL, Chesney MA, Black GW, et al. Coronary-prone behaviors in the Western Collaborative Group Study. Psychosom Med. 1988;50:153–64.PubMedGoogle Scholar
  28. 28.
    Koh KB, Cho SY, Kim JW, et al. The relationship of anger expression and alexithymia with coronary artery stenosis in patients with coronary artery diseases. Yonsei Med J. 2004;45:181–6.PubMedGoogle Scholar
  29. 29.
    Siegman AW, Dembroski TM, Ringel N. Components of hostility and severity of coronary artery disease. Psychosom Med. 1987;49:127–35.PubMedGoogle Scholar
  30. 30.
    Helmer OC, Ragland DR, Syme SL. Hostility and coronary artery disease. Am J Epidemiol. 1990;123:112–22.Google Scholar
  31. 31.
    Tennant CC, Langeluddecke PM, Fulcher G, et al. Anger and other psychological factors in coronary atherosclerosis. Psychol Med. 1987;17:425–31.PubMedGoogle Scholar
  32. 32.
    Kauhanen J, Kasplan GA, Cohen RD, et al. Alexithymia may influence the diagnosis of coronary heart disease. Psychosom Med. 1994;56:237–44.PubMedGoogle Scholar
  33. 33.
    Katon W, Sullivan M, Clark M. Cardiovascular disorders. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Wilkins; 1995.Google Scholar
  34. 34.
    Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97.PubMedGoogle Scholar
  35. 35.
    Denollet J, Sys S, Stroobant N, et al. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet. 1996;347:417–21.PubMedGoogle Scholar
  36. 36.
    Denollet J, Pedersen SS, Ong AT, et al. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J. 2006;27:171–7.PubMedGoogle Scholar
  37. 37.
    Denollet J, Martens E, Nyklícek I, et al. Clinical events in coronary patients who report low distress: adverse effect of repressive coping. Health Psychol. 2008;27:302–28.PubMedGoogle Scholar
  38. 38.
    Kim SJ, Koh KB. The relationship of stress perception with serum cholesterol in patients with essential hypertension. Kor J Psychosom Med. 1993;1:35–44.Google Scholar
  39. 39.
    Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–48.PubMedGoogle Scholar
  40. 40.
    Wittstein IS. The broken heart syndrome. Cleve Clin J Med. 2007;74(Suppl 1):S17–22.PubMedGoogle Scholar
  41. 41.
    Roh KS, Koh KB. The relationship between stress and coronary artery stenosis in patients with coronary artery diseases. Kor J Psychosom Med. 1998;6:126–35.Google Scholar
  42. 42.
    Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:953–62.PubMedGoogle Scholar
  43. 43.
    Kent LK, Shapiro PA. Depression and related psychological factors in heart disease. Harv Rev Psychiatry. 2009;17:377–88.PubMedGoogle Scholar
  44. 44.
    Frasure-Smith N, Lespérance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919–24.PubMedGoogle Scholar
  45. 45.
    Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and betathromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42:290–5.PubMedGoogle Scholar
  46. 46.
    Kawachi I, Colditz G, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89:1992–7.PubMedGoogle Scholar
  47. 47.
    Kawachi I, Sparrow D, Vokonas P, et al. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90:2225–9.PubMedGoogle Scholar
  48. 48.
    Moser DK, Riegel B, McKinley S, et al. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med. 2007;69:10–6.PubMedGoogle Scholar
  49. 49.
    Sullivan MD, LaCroix AZ, Spertus JA, et al. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol. 2000;86:1135–8. A6, A9PubMedGoogle Scholar
  50. 50.
    Ketterer MW, Huffman J, Lumley MA, et al. Five-year follow-up for adverse outcomes in males with at least minimally positive angiograms: importance of “denial” in assessing psychosocial risk factors. J Psychosom Res. 1998;44:241–50.PubMedGoogle Scholar
  51. 51.
    Levenson JL. Cardiovascular disease. In: Stoudemire A, Fogel BS, editors. Principles of medical psychiatry. New York: Grune & Stratton; 1987.Google Scholar
  52. 52.
    Burg MM, Barefoot J, Berkman L, et al. Low perceived social support and post-myocardial infarction prognosis in the enhancing recovery in coronary heart disease clinical trial: the effects of treatment. Psychosom Med. 2005;67:879–88.PubMedGoogle Scholar
  53. 53.
    Kim JW, Koh KB. The relationship between perceived stress and coping strategies in patients with coronary artery disease. J Korean Neuropsychiatr Assoc. 2000;39:288–96.Google Scholar
  54. 54.
    Mookadam F, Arthur HM. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med. 2004;164:1514–8.PubMedGoogle Scholar
  55. 55.
    Blacher RS. Paradoxical depression after heart surgery: a form of survivor syndrome. Psychoanal Q. 1978;47:267–83.PubMedGoogle Scholar
  56. 56.
    Lown B, DeSilva RA, Reich P. Psychophysiologic factors in sudden cardiac death. Am J Psychiatry. 1980;137:1325–35.PubMedGoogle Scholar
  57. 57.
    Friedman M, Thoresen CE, Gill JJ, et al. Alteration of type A behavior and reduction in cardiac recurrences in postmyocardial infarction patients. Am Heart J. 1986;108:237–48.Google Scholar
  58. 58.
    Richards SH, Anderson L, Jenkinson CE, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2017;4:CD002902.PubMedGoogle Scholar
  59. 59.
    Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA. 2003;289:3106–16.PubMedGoogle Scholar
  60. 60.
    Wenger NK, Hellerstein HK. Rehabilitation of the coronary patient. 2nd ed. New York: Wiley; 1984.Google Scholar
  61. 61.
    McLane M, Krop H, Mehta J. Psychosexual adjustment and counseling after myocardial infarction. Ann Int Med. 1980;92:514–9.PubMedGoogle Scholar
  62. 62.
    Cay EL. Psychological aspects of cardiac rehabilitation: unsolved problems. Adv Cardiol. 1982;31:237–41.PubMedGoogle Scholar
  63. 63.
    Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016;1:CD001800.Google Scholar
  64. 64.
    Anderson L, Brown JP, Clark AM, et al. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev. 2017;6:CD008895.PubMedGoogle Scholar
  65. 65.
    Glassman AH, Bigger JT. Cardiovascular effects of therapeutic doses of tricyclic anti-depressants: a review. Arch Gen Psychiatry. 1981;38:815–20.PubMedGoogle Scholar
  66. 66.
    McElroy SL, Keck PE, Friedman LM. Minimizing and managing antidepressant side-effects. J Clin Psychiatry. 1995;56(Suppl 2):49–55.PubMedGoogle Scholar
  67. 67.
    Beliles K, Stoudemire A. Psychopharmacologic treatment of depression in the medically ill. Psychosomatics. 1998;39:S2–S19.PubMedGoogle Scholar
  68. 68.
    Cohen H, Gibson G, Alderman M. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108:2–8.PubMedGoogle Scholar
  69. 69.
    Tata L, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005;91:465–71.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. Meta Anal Circ. 1991;84:1977–83.Google Scholar
  71. 71.
    Glassman AH, Walsh BJ, Roose SP. Factors related to orthostatic hypotension associated with tricyclic antidepressants. J Clin Psychiatry. 1982;43:35–8.PubMedGoogle Scholar
  72. 72.
    Roose SP, Glassman AH, Giardina EGV. Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry. 1987;44:273–5.PubMedGoogle Scholar
  73. 73.
    Vieweg WVR, Yazel J, Ballenger JC. Tricyclic antidepressant use in a patient with bundle branch blocks and ventricular ectopy. J Clin Psychiatry. 1984;45:353–5.PubMedGoogle Scholar
  74. 74.
    Buff DD, Brenner R, Kitane SS. Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. J Clin Psychiatry. 1991;52:174–6.PubMedGoogle Scholar
  75. 75.
    Ellison JM, Milofsky JE, Ely E. Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry. 1990;51:385–6.PubMedGoogle Scholar
  76. 76.
    Feder R. Bradycardia and syncope induced by fluoxetine (letter). J Clin Psychiatry. 1991;52:139.PubMedGoogle Scholar
  77. 77.
    Fisch C. Effects of sertraline on the ECG in nonelderly and elderly patients with major depression (abstract). Biol Psychiatry. 1991;29(suppl):S353–S4.Google Scholar
  78. 78.
    Stoudemire A, Fogel BS. Psychopharmacology in medical patients: an update. In: Stoudemire A, Fogel BS, editors. Medical-psychiatric practice, vol. 3. Washington, DC: American Psychiatric Press; 1995.Google Scholar
  79. 79.
    Koh KB. Stress and psychosomatic medicine. Seoul: Ilchokak; 2011.Google Scholar
  80. 80.
    Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry. 1991;148:512–6.PubMedGoogle Scholar
  81. 81.
    Johnson EM, Whyte E, Mulsant BH, et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry. 2006;14:796–802.PubMedGoogle Scholar
  82. 82.
    Warrington SJ. Clinical implications of the pharmacology of sertraline. Int Clin Psychopharmacol. 1991;6(Suppl 2):11–21.PubMedGoogle Scholar
  83. 83.
    Janowsky D, Gurtis G, Zisook S. Ventricular arrhythmias possibly aggravated by trazodone. Am J Psychiatry. 1983;140:796–7.PubMedGoogle Scholar
  84. 84.
    Lippman S, Bedford P, Manshadi M. Trazodone cardiotoxicity. Am J Psychiatry. 1983;140:1383.Google Scholar
  85. 85.
    Rowe H, Carmichael R, Lemberger L. The effect of fluoxetine on warfarin metabolism in rat and man. Life Sci. 1978;23:807–12.PubMedGoogle Scholar
  86. 86.
    Benfield P, Ward A. Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 1986;32:313–34.PubMedGoogle Scholar
  87. 87.
    Wilner KD, Lazar JD, Apseloff G. The effects of sertraline on the pharmacodynamics of warfarin in healthy volunteers (abstract). Biol Psychiatry. 1991;29(Suppl):354S–5S.Google Scholar
  88. 88.
    Shapiro P. Psychopharmacology in cardiac disease. In: Ferrando S, Levenson J, Robinson M, et al., editors. Handbook of psychopharmacology in the medically ill. Washington, DC: American Psychiatric Publishing; 2009.Google Scholar
  89. 89.
    Levenson JL, Mishra A, Bauernfeind RA. Lithium treatment of mania in a patient with recurrent ventricular tachycardia. Psychosomatics. 1986;27:594–6.PubMedGoogle Scholar
  90. 90.
    Risch SC, Groom GP, Janowsky DS. The effects of psychotropic drugs on the cardiovascular system. J Clin Psychiatry. 1982;43:16–31.PubMedGoogle Scholar
  91. 91.
    Avron J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed B-blockers. JAMA. 1986;255:357–60.Google Scholar
  92. 92.
    DeMuth GW, Ackerman SH. Alphamethyldopa and depression: a clinical study and review of the literature. Am J Psychiatry. 1983;140:534–8.PubMedGoogle Scholar
  93. 93.
    Croog SH, Levine S, Testa MA. The effects of antihypertensive therapy on the quality of life. New Engl J Med. 1986;314:1657–64.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Kyung Bong Koh
    • 1
  1. 1.Department of PsychiatryYonsei University College of MedicineSeoulKorea

Personalised recommendations